Skip to main content
. Author manuscript; available in PMC: 2019 Sep 6.
Published in final edited form as: Pediatr Nephrol. 2018 Dec 19;34(5):865–871. doi: 10.1007/s00467-018-4178-x

Fig. 1.

Fig. 1

Peak intensities of differentially expressed protein species identified by SELDI-TOF in samples from ten patients with thrombotic microangiopathy (TMA) at pre-TMA time point. Results for control serum samples are shown in red and the pre-TMA samples in blue. Top panel, IMAC30 chip. Bottom panel H50 chip. Area under the receiveroperating characteristic (ROC) curve for prediction of TMA in pre-TMA samples